|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-2-9
|
|
pubmed:abstractText |
This pilot study was designed to provide preliminary data concerning the safety and efficacy of pegylated anti-vascular endothelial growth factor (VEGF) therapy, pegaptanib, for patients with juxtapapillary or large peripheral angiomas secondary to von Hippel-Lindau (VHL) disease.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0275-004X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
150-8
|
|
pubmed:dateRevised |
2011-9-29
|
|
pubmed:meshHeading |
pubmed-meshheading:17290195-Adult,
pubmed-meshheading:17290195-Aptamers, Nucleotide,
pubmed-meshheading:17290195-Female,
pubmed-meshheading:17290195-Fluorescein Angiography,
pubmed-meshheading:17290195-Hemangioma, Capillary,
pubmed-meshheading:17290195-Humans,
pubmed-meshheading:17290195-Injections,
pubmed-meshheading:17290195-Male,
pubmed-meshheading:17290195-Middle Aged,
pubmed-meshheading:17290195-Pilot Projects,
pubmed-meshheading:17290195-Prospective Studies,
pubmed-meshheading:17290195-Retinal Neoplasms,
pubmed-meshheading:17290195-Tomography, Optical Coherence,
pubmed-meshheading:17290195-Vascular Endothelial Growth Factor A,
pubmed-meshheading:17290195-Visual Acuity,
pubmed-meshheading:17290195-Vitreous Body,
pubmed-meshheading:17290195-von Hippel-Lindau Disease
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.
|
|
pubmed:affiliation |
Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
